SP600125: Difference between revisions

From XenWiki
Jump to navigation Jump to search
imported>Kevin
Created page with "==Description== MAPK/JNK inhibitor. A novel and selective inhibitor of c-Jun N-terminal kinase (JNK) SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP t..."
 
imported>Kevin
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 2: Line 2:
MAPK/JNK inhibitor.
MAPK/JNK inhibitor.


A novel and selective inhibitor of c-Jun N-terminal kinase (JNK)
"A novel and selective inhibitor of c-Jun N-terminal kinase (JNK)
SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP to inhibit the phosphorylation of c-Jun. It prevents the activation of inflammatory genes such as COX-2, IL-2 IFN-γ and TNF-α.8,9 It prevents the activation of JNK after brain ischemia and may be effective in treatment of ischemic stroke.10
SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP to inhibit the phosphorylation of c-Jun. It prevents the activation of inflammatory genes such as COX-2, IL-2 IFN-γ and TNF-α.8,9 It prevents the activation of JNK after brain ischemia and may be effective in treatment of ischemic stroke.10"
*Sigma Description
*-Sigma Product Description


[[File:SP600125.png|frame|right|SP600125 structure, photo from Sigma-Aldrich]]
[[File:SP600125.png|frame|right|SP600125 structure, photo from Sigma-Aldrich]]
Line 23: Line 23:


==References==
==References==
*[https://pubchem.ncbi.nlm.nih.gov/compound/8515 PubChem]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=48899 Cizelsky et al., 2014]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=48899 Cizelsky et al., 2014]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=46881 Zhang et al., 2013]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=46881 Zhang et al., 2013]
Line 53: Line 54:
*[http://www.xenbase.org/literature/article.do?method=display&articleId=46756 Dush et al., 2013]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=46756 Dush et al., 2013]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=50349 Luu et al., 2015]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=50349 Luu et al., 2015]
*[http://www.xenbase.org/literature/article.do?method=display&articleId=51468 Martinez et al., 2015]




>28 Xenbase articles contain a reference to SP600125 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso]
>28 Xenbase articles contain a reference to SP600125 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso]
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]]

Latest revision as of 05:44, 4 November 2015

Description

MAPK/JNK inhibitor.

"A novel and selective inhibitor of c-Jun N-terminal kinase (JNK) SP600125 is an anthrapyrazolone inhibitor of JNK that competes with ATP to inhibit the phosphorylation of c-Jun. It prevents the activation of inflammatory genes such as COX-2, IL-2 IFN-γ and TNF-α.8,9 It prevents the activation of JNK after brain ischemia and may be effective in treatment of ischemic stroke.10"

  • -Sigma Product Description
SP600125 structure, photo from Sigma-Aldrich

Genes Affected

mapk8 mapk1

Suppliers

Usage Notes

References


>28 Xenbase articles contain a reference to SP600125 according to textpresso